Breakout Session 3A
This panel will explore the multiple facets and applications of big data in life sciences as well as explore whether big data will consistently enable better and more timely medicines.
Martin LeBlanc, President & CEO, Caprion Biosicences Inc.
Rob Silverman, Head of Venture, Roche
Dr. Eiry Wynn Roberts, Vice President, Eli Lilly and Company
Dr. Luc Marengere, Managing Partner, TVM Life Science Venture Capital
Dr. Peter Bauer, Chief Scientific Officer, Centogene